PMID:16004994: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php
imported>Wikientrybot
change PMID template to TableEdit version
Line 1: Line 1:
{{RightTOC}}
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.121983.N52238ba96ffe0-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="N52238ba96ffe0"  class=" tableEdit PMID_info_table" 


<span style = 'font-size: large'> '''Rothnie, A, Storm, J, McMahon, R, Taylor, A, Kerr, ID and Callaghan, R'''  (2005) The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment.''FEBS Lett.'' '''579''':3984-90</span>
{|{{Prettytable}} align = 'center' width= '70%'
|-
|-
|{{TableHeadingColor}} |'''Abstract''' || The transmembrane (TM) domains in P-glycoprotein (P-gp) contain the drug binding sites and undergo conformational changes driven by nucleotide catalysis to effect translocation. However, our understanding of exactly which regions are involved in such events remains unclear. A site-directed labelling approach was used to attach thiol-reactive probes to cysteines introduced into transmembrane segment 6 (TM6) in order to perturb function and infer involvement of specific residues in drug binding and/or interdomain communication. Covalent attachment of coumarin-maleimide at residue 339C within TM6 resulted in impaired ATP hydrolysis by P-gp. The nature of the effect was to reduce the characteristic modulation of basal activity caused by transported substrates, modulators and the potent inhibitor XR9576. Photoaffinity labelling of P-gp with [(3)H]-azidopine indicated that residue 339C does not alter drug binding per se. However, covalent modification of this residue appears to prevent conformational changes that lead to drug stimulation of ATP hydrolysis.
!align=left  |Citation
</noinclude>
||
'''No author listed'''  (2005) The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment. ''FEBS Lett.'' '''579''':3984-90
|-
!align=left  |Abstract
||
The transmembrane (TM) domains in P-glycoprotein (P-gp) contain the drug binding sites and undergo conformational changes driven by nucleotide catalysis to effect translocation. However, our understanding of exactly which regions are involved in such events remains unclear. A site-directed labelling approach was used to attach thiol-reactive probes to cysteines introduced into transmembrane segment 6 (TM6) in order to perturb function and infer involvement of specific residues in drug binding and/or interdomain communication. Covalent attachment of coumarin-maleimide at residue 339C within TM6 resulted in impaired ATP hydrolysis by P-gp. The nature of the effect was to reduce the characteristic modulation of basal activity caused by transported substrates, modulators and the potent inhibitor XR9576. Photoaffinity labelling of P-gp with [(3)H]-azidopine indicated that residue 339C does not alter drug binding per se. However, covalent modification of this residue appears to prevent conformational changes that lead to drug stimulation of ATP hydrolysis.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16004994 PubMed]
Online version:[http://dx.doi.org/10.1016/j.febslet.2005.06.030 10.1016/j.febslet.2005.06.030]
|-
|-
|{{TableHeadingColor}} nowrap |'''Links''' ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16004994 PubMed]
!align=left  |Keywords
||
Adenosine Triphosphatases/chemistry; Adenosine Triphosphate/chemistry; Animals; Baculoviridae/metabolism; Binding Sites; Catalysis; Cell Line; Cell Membrane/metabolism; Coumarins/chemistry; Cysteine/chemistry; Hydrolysis; Insects; Kinetics; Linear Models; Mutagenesis, Site-Directed; Nicardipine/pharmacology; P-Glycoprotein/metabolism; Paclitaxel/pharmacology; Protein Binding; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Protein Transport; Quinolines/pharmacology; Recombinant Proteins/chemistry; Sulfhydryl Compounds/chemistry; Time Factors; Vinblastine/pharmacology
 
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.121983.N52238ba96ffe0&page=121983&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
|}
 
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.121983.N52238ba96ffe0-->
==Significance {{HelpIcon|Help:Literature}} ==
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
{{LitSignificance}}

Revision as of 18:47, 1 September 2013

Citation

No author listed (2005) The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment. FEBS Lett. 579:3984-90

Abstract

The transmembrane (TM) domains in P-glycoprotein (P-gp) contain the drug binding sites and undergo conformational changes driven by nucleotide catalysis to effect translocation. However, our understanding of exactly which regions are involved in such events remains unclear. A site-directed labelling approach was used to attach thiol-reactive probes to cysteines introduced into transmembrane segment 6 (TM6) in order to perturb function and infer involvement of specific residues in drug binding and/or interdomain communication. Covalent attachment of coumarin-maleimide at residue 339C within TM6 resulted in impaired ATP hydrolysis by P-gp. The nature of the effect was to reduce the characteristic modulation of basal activity caused by transported substrates, modulators and the potent inhibitor XR9576. Photoaffinity labelling of P-gp with [(3)H]-azidopine indicated that residue 339C does not alter drug binding per se. However, covalent modification of this residue appears to prevent conformational changes that lead to drug stimulation of ATP hydrolysis.

Links

PubMed Online version:10.1016/j.febslet.2005.06.030

Keywords

Adenosine Triphosphatases/chemistry; Adenosine Triphosphate/chemistry; Animals; Baculoviridae/metabolism; Binding Sites; Catalysis; Cell Line; Cell Membrane/metabolism; Coumarins/chemistry; Cysteine/chemistry; Hydrolysis; Insects; Kinetics; Linear Models; Mutagenesis, Site-Directed; Nicardipine/pharmacology; P-Glycoprotein/metabolism; Paclitaxel/pharmacology; Protein Binding; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Protein Transport; Quinolines/pharmacology; Recombinant Proteins/chemistry; Sulfhydryl Compounds/chemistry; Time Factors; Vinblastine/pharmacology

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

References

See Help:References for how to manage references in EcoliWiki.